ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,316 | -68.0% | 311,944 | -62.0% | 0.22% | -67.0% |
| Q2 2023 | $759,460 | -58.0% | 821,038 | -50.6% | 0.66% | -28.7% |
| Q1 2023 | $1,810,310 | -28.5% | 1,660,835 | -4.2% | 0.93% | -9.5% |
| Q4 2022 | $2,530,525 | +31.6% | 1,733,236 | -3.1% | 1.03% | +64.2% |
| Q3 2022 | $1,923,000 | -38.0% | 1,788,517 | -1.9% | 0.63% | -42.5% |
| Q2 2022 | $3,101,000 | -30.3% | 1,824,065 | -15.6% | 1.09% | -7.2% |
| Q1 2022 | $4,451,000 | +32.2% | 2,160,890 | +140.7% | 1.17% | +44.5% |
| Q4 2021 | $3,366,000 | -29.0% | 897,579 | -2.2% | 0.81% | -24.8% |
| Q3 2021 | $4,743,000 | -27.7% | 917,488 | -40.4% | 1.08% | -40.1% |
| Q2 2021 | $6,558,000 | +34.9% | 1,539,435 | +68.1% | 1.80% | +42.1% |
| Q1 2021 | $4,862,000 | -16.3% | 915,711 | -15.1% | 1.27% | -39.5% |
| Q4 2020 | $5,811,000 | +26.7% | 1,078,177 | +87.7% | 2.10% | +54.6% |
| Q3 2020 | $4,585,000 | -5.2% | 574,502 | +18.9% | 1.36% | +411.7% |
| Q2 2020 | $4,836,000 | +1011.7% | 483,103 | +202.3% | 0.26% | +34.5% |
| Q1 2020 | $435,000 | – | 159,826 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Matrix Capital Management Company, LP | 38,974,185 | $166,030,000 | 1.81% |
| Endurant Capital Management LP | 1,539,435 | $6,558,000 | 1.80% |
| NEA Management Company, LLC | 17,082,611 | $72,772,000 | 0.95% |
| PFM Health Sciences, LP | 3,627,900 | $15,455,000 | 0.48% |
| GSA CAPITAL PARTNERS LLP | 513,388 | $2,187,000 | 0.25% |
| Baker Brothers Advisors | 9,830,877 | $41,880,000 | 0.18% |
| Avoro Capital Advisors LLC | 2,024,400 | $8,624,000 | 0.15% |
| Vigilare Wealth Management | 54,250 | $231,000 | 0.14% |
| AlphaCentric Advisors LLC | 120,000 | $511,000 | 0.14% |
| Rock Springs Capital Management LP | 1,545,000 | $6,582,000 | 0.13% |